Stay updated with breaking news from Add on payment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
To embed, copy and paste the code into your website or blog: On April 27, 2021, CMS issued the fiscal year (FY) 2022 proposed rule for the hospital inpatient prospective payment system (IPPS) and long-term care hospital (LTCH) prospective payment system (the Proposed Rule). Among other proposals, the Proposed Rule proposes increases to IPPS and LTCH payment rates, repealing the market-based MS-DRG Relative Weight Policy, changing the new COVID-19 treatment add-on payment, changes related to Graduate Medical Education, changes to the Medicare wage index, revisions to the Medicare Geographic Classification Review Board rules, changes to organ procurement policies, proposals related to bad debt, Medicare DSH and uncompensated care payments, and proposed Medicare Shared Savings Program changes. This article provides an overview of the key proposals in the Proposed Rule. Comments to the proposed rule must be submitted by 5 pm EST on June 28, 2021. ....
Highlights The Centers for Medicare & Medicaid Services (CMS) on April 27, 2021, released the Fiscal Year (FY) 2022 Medicare Hospital Inpatient Prospective Payment System (IPPS) and Long Term Care Hospital (LTCH) Prospective Payment System (PPS) Proposed Rule, which will affect discharges occurring on or after Oct. 1, 2021. The Proposed Rule would update the payment policies and annual payment rates for the inpatient payment system, update various quality programs and evaluate New Technology Add-On Payment (NTAP) applications, among other changes. Comments on the Proposed Rule are due by June 28, 2021, and a final rule is expected by Aug. 1, 2021. The Centers for Medicare & Medicaid Services (CMS) on April 27, 2021, released the Fiscal Year (FY) 2022 Medicare Hospital Inpatient Prospective Payment System (IPPS) and Long Term Care Hospital (LTCH) Prospective Payment System (PPS) Proposed Rule, which will affect discharges occurring on or after Oct. 1, 2021. A CMS fa ....
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and analyses; and other health policy news. Week in Review Highlight of the Week: This week, CMS released its FY 2022 Hospital Inpatient Prospective Payment System and Long-Term Care Hospital Rates Proposed Rule. Read more about the rule and other news below. I. Regulations, Notices & Guidance On April 26, 2021, the Food and Drug Administration (FDA) issued guidance entitled, Nonclinical Testing of Individualized Antisense Oligonucleotide Drug Products for Severely Debilitating or Life-Threatening Diseases; Draft Guidance for Sponsor-Investigators. FDA is publishing this draft guidance to help sponsor-investigators with developing the nonclinical information that FDA recommends to support an investigational new drug application (IND) f ....
Electronic Reportable Laboratory Result Reporting. Requiring hospitals to report these four measures would help to prepare public health agencies to respond to future health threats and a long-term COVID-19 recovery by strengthening public health functions, including early warning surveillance, case surveillance and vaccine uptake, which will increase the information available to help hospitals better serve their patients, said CMS officials. The new requirements would enable nationwide syndromic surveillance that could help provide early notices of emerging disease outbreaks, according to CMS. Additionally, automated case and lab reporting would speed response times for public health agencies, while broader and more granular visibility into immunization uptake patterns would help these agencies tailor their vaccine distribution plans. ....
To embed, copy and paste the code into your website or blog: Over the past weeks, CMS has issued billing and coding guidance for newly authorized COVID-19 vaccines and treatments. This guidance information further implements policy and regulatory revisions made by CMS in the Interim Final Rule published in the Federal Register on November 6, 2020 (IFR), the agency s fourth COVID-19 rulemaking. Since the issuance of the IFR, CMS has provided instructions and toolkits via its website concerning billing for COVID-19 vaccines and monoclonal antibody COVID-19 infusion, and most recently, on December 18, 2020, for the new COVID-19 Treatments Add-On Payment payable to hospitals under the Medicare Inpatient Prospective Payment System (IPPS). ....